Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients

Overview of attention for article published in Journal of Cardiac Failure, December 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy: 1 policy source
patent: 4 patents

guideline: 7 clinical guideline sources

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Left ventricular assist device (LVAD) as destination therapy for patients with endstage heart failure

Cited by Norwegian Institute of Public Health on 11 Nov 2013

The Norwegian Institute of Public Health is a government agency under the Ministry of Health and Care Services. Our employees are located in Oslo, Bergen, Levanger, Tynset og Trondheim.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.